Suppr超能文献

口服抗凝治疗期间使用合成替代物估算斯图尔特因子。初步结果(作者译)

[Estimation of Stuart factor using a synthetic substitute during oral anticoagulant treatment. Preliminary results (author's transl)].

作者信息

Conard J, Gradelet A, Samama M

出版信息

Ann Biol Clin (Paris). 1981;39(2):81-3.

PMID:7258751
Abstract

The estimation of Stuart Factor (Factor X) with a new synthetic substrate S-2337, and the prothrombin time were compared in 91 patients treated with oral anticoagulants for more than one month. There was a good correlation between the two tests (r = 0.79 and 0.81 depending on the thromboplastin used). The results of out short study suggest a therapeutic zone between 20 p cent and 32 p cent of factor X but these values require confirmation. This method may constitute a progress in the laboratory supervision of treatment with coumarin derivatives for it permits better standardisation of the results and may easily be adapted to an autoanalyser.

摘要

采用新型合成底物S - 2337对91例接受口服抗凝剂治疗超过1个月的患者进行了斯图尔特因子(因子X)测定,并与凝血酶原时间进行了比较。两项检测之间存在良好的相关性(根据所用凝血活酶不同,r分别为0.79和0.81)。我们简短研究的结果表明,因子X在20%至32%之间可能为治疗区间,但这些数值尚需确认。该方法可能在香豆素衍生物治疗的实验室监测方面取得了进展,因为它能使结果更好地标准化,并且可能很容易适配自动分析仪。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验